Lianjun Ma
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Circular RNAs in diseases 5
-
- MicroRNA in disease regulation 6
- Cancer, Lipids, and Metabolism 4
- Cancer-related molecular mechanisms research 4
- Co-authors
- Ying‐Wei Yang (5 shared papers)Jie Yang (3 shared papers)Dihua Dai (3 shared papers)Xin‐Yue Lou (2 shared papers)Lesheng Teng (1 shared paper)Xi Zhang (1 shared paper)Lei Song (4 shared papers)Xiaoxue Bai (6 shared papers)
- Journals
- Theranostics (3 papers)Frontiers in Cell and Developmental Biology (2 papers)BioMed Research International (2 papers)Frontiers in Pharmacology (2 papers)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lianjun Ma
30 papers receiving 990 citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 227
- Biomaterials 182
- Biomedical Engineering 363
- Inorganic Chemistry 105
- Molecular Biology 359
Countries citing papers authored by Lianjun Ma
This map shows the geographic impact of Lianjun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianjun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianjun Ma more than expected).
Fields of papers citing papers by Lianjun Ma
This network shows the impact of papers produced by Lianjun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianjun Ma. The network helps show where Lianjun Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Lianjun Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer therapy: from single to combination therapy Hit paper breakdown → | 2022 | 180 |
| 2 | 2019 | 114 | |
| 3 | 2019 | 104 | |
| 4 | 2017 | 74 | |
| 5 | 2018 | 62 | |
| 6 | 2018 | 59 | |
| 7 | 2016 | 51 | |
| 8 | 2020 | 47 | |
| 9 | 2017 | 40 | |
| 10 | 2022 | 29 | |
| 11 | 2018 | 29 | |
| 12 | 2014 | 28 | |
| 13 | 2019 | 23 | |
| 14 | 2017 | 20 | |
| 15 | 2016 | 20 | |
| 16 | 2017 | 19 | |
| 17 | 2024 | 16 | |
| 18 | 2018 | 14 | |
| 19 | 2017 | 11 | |
| 20 | 2022 | 10 |
About Lianjun Ma
Lianjun Ma is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Biomaterials and Biomedical Engineering, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers), Ferroptosis and cancer prognosis (5 papers), Cancer, Lipids, and Metabolism (4 papers), Metal-Organic Frameworks: Synthesis and Applications (4 papers), Cancer-related molecular mechanisms research (4 papers), Nanoplatforms for cancer theranostics (3 papers) and Supramolecular Self-Assembly in Materials (3 papers). The work is most often cited by research in Cancer Research (227 citations), Biomaterials (182 citations), Biomedical Engineering (363 citations), Inorganic Chemistry (105 citations) and Molecular Biology (359 citations). Lianjun Ma has collaborated with scholars based in China and United States. Frequent co-authors include Ying‐Wei Yang, Jie Yang, Dihua Dai, Xin‐Yue Lou, Lesheng Teng, Xi Zhang, Lei Song, Xiaoxue Bai, Nan Song and Hui Gao. Their work appears in journals such as Theranostics, Frontiers in Cell and Developmental Biology, BioMed Research International, Frontiers in Pharmacology and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.